AT7519 TFA

SKU: orb1704672

Description

AT7519 is a potent, multi-target cyclin-dependent kinase (CDK) inhibitor with IC50 values ranging from 0.018 to 0.66 µM against CDK1, CDK2, CDK4, CDK5, and CDK6. It is widely used in cancer research to study cell cycle arrest and apoptosis, demonstrating antitumor activity in both in vitro and in vivo experimental models.

Research Area

Cell Biology

Key Properties

• CAS Number: 1431697-85-6
• MW: 496.27
• Formula: C₁₈H₁₈Cl₂F₃N₅O₄
• SMILES: OC(=O)C(F)(F)F.Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1
• Target: Others,CDK

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

71576690